OSE Immunotherapeutics to Host an “Immuno-Oncology R&D Day” On October 12th, 2021

NEXT STORY
Tiziana Life Sciences Plc – Results of Court Meeting and General Meeting
PREV STORY
ProSomnus® Sleep Technologies Adds John Remmers, MD, to Leadership Team
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for Complement-Mediated Diseases

author_avatar
NASDAQ Market News

Calithera to Present at the 2021 Jefferies London Healthcare Conference

author_avatar
NASDAQ Market News

BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP™ System

author_avatar
NASDAQ Market News